RxDoctor Payments Data

Tushar Patel, MD

Orthopaedic Surgery · Chevy Chase, MDNPI 1922021997

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $228,479 of the $294,767 with a category attached, or 77.5%. 23 manufacturers reported payments, led by Orthofix Medical, Inc. at 52.3% of the total. Among orthopaedic surgery clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$294,767in general payments, 2019–2025

Across 214 payments — averaging $1377.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$154K
  • Depuy Synthes Products, Inc.$57K
  • Seaspine Orthopedics Corporation$56K
  • Stryker$10K
  • Lifenet Health$6K
  • Medical Device Business Services, Inc.$5K
  • plus $7K from 17 others

What the payments were for

  • Royalty or licence$228,47978%
  • Consulting fees$50,08917%
  • Travel & lodging$6,6862%
  • Food & beverage$9,5133%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$294,767 in reported general payments places this provider in the 95th percentile of 378 orthopaedic surgery providers in Maryland.

See all orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$487,990
Medicare patients
865
Services billed
2,841

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium179$1,758
Methylprednisolone180$1,396
Gabapentin53$580
Celecoxib23$381
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen43$355
Amitriptyline Hcl14$350
Pregabalin12$319
Diazepam80$203
Tramadol Hcl27$119
Oxycodone Hcl14$73
Alprazolam13$19

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Chevy Chase

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →